epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Azulfidine EN-tabs
    sulfasalazine
  • remove Simulect
    basiliximab

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Azulfidine EN-tabs (sulfasalazine) + Simulect (basiliximab)

Caution Advised


sulfasalazine + basiliximab

caution advised: combo may incr. risk of serious infection (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information